Skip to main content

Peer Review reports

From: Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial

Original Submission
30 Jul 2022 Submitted Original manuscript
8 Sep 2022 Reviewed Reviewer Report
4 Jan 2023 Reviewed Reviewer Report
13 Feb 2023 Author responded Author comments - Mohammad Ebrahim Khamseh
Resubmission - Version 2
13 Feb 2023 Submitted Manuscript version 2
25 Feb 2023 Author responded Author comments - Mohammad Ebrahim Khamseh
Resubmission - Version 3
25 Feb 2023 Submitted Manuscript version 3
13 Jun 2023 Author responded Author comments - Mohammad Ebrahim Khamseh
Resubmission - Version 4
13 Jun 2023 Submitted Manuscript version 4
28 Jun 2023 Reviewed Reviewer Report
12 Jul 2023 Reviewed Reviewer Report
25 Jul 2023 Author responded Author comments - Mohammad Ebrahim Khamseh
Resubmission - Version 5
25 Jul 2023 Submitted Manuscript version 5
26 Jul 2023 Reviewed Reviewer Report
9 Aug 2023 Author responded Author comments - Mohammad Ebrahim Khamseh
Resubmission - Version 6
9 Aug 2023 Submitted Manuscript version 6
6 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
6 Sep 2023 Editorially accepted
23 Sep 2023 Article published 10.1186/s12876-023-02948-4

You can find further information about peer review here.

Back to article page